BRIAN GAYNOR: The rise and rise of Fisher & Paykel Healthcare

BRIAN GAYNOR: The rise and rise of Fisher & Paykel Healthcare
Brian Gaynor
Fisher & Paykel Healthcare has been a fantastic investment in recent years, particularly during the covid-19 pandemic.At the end of June, the medical supplies company had a share market value of $20.5 billion, making it the first $20 billion NZX company. Its performance during the covid-19 crisis has been amazing with its total market value surging $7.1 billion between Jan. 31 and June 30. This value accretion was greater than the total value of all but four other NZX listed stocks: A2 Milk, Meridian Energy, Auckland International...

More Opinion

Let the people hold the paintbrush
Policy He Poneketanga

Deb Te Kawa: Let the people hold the paintbrush

Central government works best when communities get a real say.

Deb Te Kawa 13 Jan 2025
BlackRock gives foreign investment a bad name
Opinion

Pattrick Smellie: BlackRock gives foreign investment a bad name

If it had set out to be disliked in NZ, BlackRock would be succeeding handsomely.

Pattrick Smellie 13 Jan 2025
My top columns from 2024
Opinion

Dileepa Fonseka: My top columns from 2024

From Spark losing its literal Mojo to fleeing talent and overpriced houses. 

Dileepa Fonseka 11 Jan 2025